Summary
We studied thrombin-induced metabolism of phosphoinositide, protein phosphorylation and platelet aggregation in platelets from 32 NIDDM patients and 12 control subjects. To clarify the effect of diet, sulphonylureas, or insulin treatment, the subjects were divided into three groups based on the type of treatment. Thrombin-induced platelet aggregation was measured with an aggregometer. Low-dose thrombin (0.25 U/ml)-stimulated platelet aggregation in diabetic patients was significantly increased compared with the control subjects. Platelet aggregation in the sulphonylurea and insulin groups was significantly lower than in the diet group. On the other hand, in platelets incubated with [32P]orthophosphate, thrombin-induced incorporation of 32P radioactivity into phosphatidic acid (PA) was significantly lower in the sulphonylurea and insulin groups than in the diet group. Thrombin-induced incorporation of [32P] radioactivity into phosphatidylinositol (PIP) for 10 s was significantly higher in the sulphonylurea group than in the diet group. There were no differences in thrombin-induced 47 kDa protein phosphorylation between platelets from the diet, sulphonylurea, or insulin groups. These results suggest that sulphonylureas and insulin induce suppression of thrombin-induced activation of phospholipase C, which mediates hydrolysis of PIP and PIP2 and production of PA, which leads to inhibition of platelet aggregation.
Article PDF
Similar content being viewed by others
Abbreviations
- NIDDM:
-
Non-insulin-dependent diabetes mellitus
- IDDM:
-
insulin-dependent diabetes mellitus
- PA:
-
phosphatidic acid
- PI:
-
phosphatidylinositol
- PIP:
-
phosphatidylinositol 4-monophosphate
- PIP2 :
-
phosphatidylinositol 4,5-bisphosphate
- TPA:
-
12-O-tetradecanoylphorbol-13-actate
- IP3 :
-
inositol 1,4,5-trisphophate
- E/I:
-
expiration/inspiration
- HPLTC:
-
high performance thin layer chromatography
References
Rittenhouse-Simmons S (1979) Production of diglyceride from phosphatidylinositol in activated platelets. J Clin Invest 63: 580–587
Broekman MJ, Ward JW, Marcus AJ (1980) Phospholipid metabolism in stimulated human platelets. J Clin Invest 66: 275–283
Billah MM, Lapetina EG (1982) Rapid decrease of phosphatidylinositol 4,5-bisphosphate in thrombin-stimulated platelets. J Biol Chem 25: 12705–12708
Imai A, Nakashima S, Nozawa Y (1983) The rapid polyphosphoinositide mediated stimulation of human platelets. Biochem Biophys Res Commun 110: 108–115
Brass LF, Joseph SK (1985) A role of inositol trisphosphate in intracellular Ca2+ mobilization in platelet activation. J Biol Chem 260: 15172–15179
Kaibuchi K, Takai Y, Sawamura M, Hoshijima M, Fujikura T, Nishizuka Y (1983) Synergistic functions of protein phosphorylation and calcium mobilization in platelet activation. J Biol Chem 258: 6701–6704
Lapetina EG, Reep B, Ganong BR, Bell RM (1985) Exogenous sn-1,2-diacylglycerols containing saturated fatty acids function as bioregulators of protein kinase C in human platelets. J Biol Chem 260: 1358–1361
Marcus AJ (1978) The role of lipids in platelet function: with particular reference to the arachidonic acid pathway. J Lipid Res 19: 793–826
Bern MM (1978) Platelet function in diabetes mellitus. Diabetes 27: 342–350
Colwell JA, Winocour PD, Lopes-Virella M, Halushka PV (1983) New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med 75: 67–80
Takahashi R, Morita I, Murota S, Shiraki M, Ito M, Orimo H (1983) Dietary arachidonic acid supplementation increase thromboxane synthesizing activity in platelets from diabetes. Prostaglandins Leukot Med 75: 67–80
Takahashi R, Morita I, Saito Y, Ito H, Murato S (1984) Increased arachidonic acid incorporation into platelet phospholipids in type 2 (non-insulin-dependent) diabetes. Diabetologia 26: 134–137
Bastyr EJ, Kadrofske MM, Dershimer RC, Vinik AI (1989) Decreased platelet phosphoinositide turnover and enhanced platelet activation in IDDM. Diabetes 38: 1097–1102
Ishii H, Umeda F, Hashimoto T, Nawata H (1990) Changes in phosphoinositide turnover, Ca2+ mobilization, and protein phosphorylation in platelets from NIDDM patients. Diabetes 39: 1561–1568
Ishizuka T, Yasuda K, Takeda N et al. (1991) Thrombin-induced breakdown of phosphoinositides in platelets from patients with NIDDM. Endocrinol Japon 38: 81–87
Chimori K, Miyazaki S, Kosaka J, Sakanaka A, Yasuda K, Miura K (1987) The significance of autonomic neuropathy in the elevation of inactive renin in diabetes mellitus. Clin Exp Hypertens [A] 9: 19–32
Marche P, Koutouzov S, Meyer P (1982) Metabolism of phosphoinositides in the rat erythrocyte membrane. A reapraisal of the effect of magnesium on the 32P incorporation into phosphoinositides. Biochem Biophys Acta 710: 332–340
Bligh EG, Dyer WJ (1959) Rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911–917
Jolles J, Schrama LH, Gispen WJ (1981) Calcium-dependent turnover of brain polyphosphoinositides in vitro after prelabelling in vivo. Biochem Biophys Acta 666: 90–98
Born GVT (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927–929
Huang EM, Detwiller TC (1987) Thrombin induced phosphoinositide hydrolysis in platelets: receptor occupancy and desensitization. Biochem J 242: 11–18
Verhoeven AJM, Gorter G, Mommersteeg ME, Akkerman JWN (1985) The energetics of platelet responses: energy consumption during shape change and aggregation with special reference to protein phosphorylation and the phosphoinositide cycle. Biochem J 228: 451–462
Holmsen H, Dangelmaier CA, Rongved S (1984) Tight coupling of thrombin-induced acid hydrolase secretion and phosphatidate synthesis to receptor occupancy in human platelets. Biochem J 222: 157–167
Kalofoutis A, Lekakis J (1981) Change of platelet phospholipids in diabetes mellitus. Diabetologia 21: 540–543
Siess W, Weber PC, Lapetina EG (1984) Activation of phospholipase C is dissociated from arachidonate metabolism during platelet shape change induced by thrombin or platelet-activating factor. J Biol Chem 259: 8286–8292
Tyers M, Rachubinski RA, Stewart MI et al. (1988) Molecular cloning and expression of protein kinase C substrate of platelets. Nature 333: 470–473
Burrows AW, Chavin SI, Hockaday TDR (1978) Plasmathromboglobulin concentrations in diabetes mellitus. Lancet I: 235–237
Preston FE, Ward JD, Marcola BH, Porter NR, Timperley WR (1978) Elevated β-thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy. Lancet I: 238–239
Borsey DQ, Dawes J, Fraser DM, Prowse CV, Elton RA, Clarke BF (1980) Plasma beta-thromboglobulin in diabetes mellitus. Diabetologia 18: 353–357
Segel J, Colwell JA, Crook L, Laimins M (1975) Increased platelet aggregation in early diabetes mellitus. Ann Intern Med 82: 733–738
Bensoussan D, Levy-Toledano S, Possa P, Caen J, Canivet J (1975) Platelet hyperaggregation and increased plasma level of von Willebrand factor in diabetics with retinopathy. Diabetologia 11: 307–312
Besterman JM, Duronio V, Cuatrecasas P (1986) Rapid formation of diacylglycerol from phosphatidylcholine: a pathway for generation of a second messenger. Proc Natl Acad Sci USA 83: 6785–6789
Bocckino SB, Blackmore PF, Wilson PB, Exton JH (1987) Phosphatidate accumulation in hormone-treated hepatocytes via a phospholipase D mechanism. J Biol Chem 262: 15 309–15 315
Farese RV, Konda TS, Davis JS, Standaert ML, Pollet RJ, Cooper DR (1987) Insulin rapidly increases diacylglycerol by activating de novo phosphatidic acid synthesis. Science 236: 586–589
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ishizuka, T., Taniguchi, O., Yamamoto, M. et al. Thrombin-induced platelet aggregation, phosphoinositide metabolism and protein phosphorylation in NIDDM patients treated by diet, sulphonylurea or insulin. Diabetologia 37, 632–638 (1994). https://doi.org/10.1007/BF00403384
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00403384